BD-32-GI59_10uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=10uM, 2-[1-[3,5-Di(propan-2-yloxy)phenyl]-3-ethyl-7-methoxyisoquinolin-6-yl]oxyethanol, Phosphodiesterase IV Inhibitors targeting PDE4A, PDE4B, PDE4D (Novartis, 9954871)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/9954871
Similar Terms
Downloads & Tools

Genes

21 genes differentially expressed following the BD-32-GI59_10uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
MT2A metallothionein 2A 0.923115
VGF VGF nerve growth factor inducible 0.605698
C11ORF24 chromosome 11 open reading frame 24 0.524664
TGM2 transglutaminase 2 0.523673
NNMT nicotinamide N-methyltransferase 0.417147
DDIT4 DNA-damage-inducible transcript 4 0.413133
DGUOK deoxyguanosine kinase 0.375329
AVPI1 arginine vasopressin-induced 1 0.357103
BEX2 brain expressed X-linked 2 0.287071
ID3 inhibitor of DNA binding 3, dominant negative helix-loop-helix protein 0.282087
TMSB10 thymosin beta 10 0.277808
MT1E metallothionein 1E 0.262618
BOLA2B bolA family member 2B 0.255332
TIMP1 TIMP metallopeptidase inhibitor 1 0.251898
INSL4 insulin-like 4 (placenta) 0.227356

decreased expression

Symbol Name Standardized Value
SCD stearoyl-CoA desaturase (delta-9-desaturase) -1.10406
PDLIM1 PDZ and LIM domain 1 -0.4522
WNT11 wingless-type MMTV integration site family, member 11 -0.445374
TMEM51 transmembrane protein 51 -0.339093
LOXL4 lysyl oxidase-like 4 -0.324198
FASN fatty acid synthase -0.20216